-
NMPA Announcement on Issuing the Rules for Registration and Notification Dossiers of Cosmetics
2021-03-04
The NMPA has developed the Rules for Registration and Notification Dossiers of Cosmetics, which is hereby issued and shall take effect as of May 1, 2021.
-
NMPA Announcement on Issuing the Rules for Registration and Notification Dossiers of New Cosmetic Ingredients
2021-03-04
The NMPA has developed the Rules for Registration and Notification Dossiers of New Cosmetic Ingredients, which is hereby issued and shall take effect as of May 1, 2021.
-
NMPA Announcement on Revising the Package Insert of Misoprostol Tablets for Obstetrical and Gynecological Application
2021-02-26
To further protect public medication safety, the NMPA decided to revise the package insert of Misoprostol Tablets for obstetrical and gynecological application. Relevant issues are hereby announced as follows.
-
NMPA Notice on Issuing the Requirements for Change Items of Marketed Traditional Chinese Medicines and Application Dossiers
2021-02-24
The NMPA has organized to formulate the Requirements for Change Items of Marketed Traditional Chinese Medicines and Application Dossiers, which has been issued and implemented on February 23.
-
NMPA Announcement on Issuing the Catalogue of Reference Preparations of Generic Drugs (Thirty-eighth Batch)
2021-02-23
On February 20, the Catalogue of Reference Preparations of Generic Drugs (Thirty-eighth Batch) was issued, upon review and determination by the NMPA Experts Committee of Quality and Efficacy Consistency Evaluation of Generic Drugs.
-
NMPA Announcement on Revising the Package Insert of Methimazole Preparations
2021-02-09
To further protect public medication safety, the NMPA decided to revise the package insert of Methimazole Preparations. The relevant issues are hereby announced as follows.